Saxon Securities to
Saxon Securities to Offer FDIC-Insured Brokered CD Portfolios on Envestnet Platform
31 mars 2016 09h00 HE | Saxon Securities
San Francisco, March 31, 2016 (GLOBE NEWSWIRE) -- Saxon Securities, a recognized platform provider of separately managed account FDIC-Insured brokered certificates of deposit (CDs) investment...
Options on Futures Now Available on Wolverine Execution Services Trading Platform
12 mai 2015 15h22 HE | Wolverine Execution Services
CHICAGO, IL--(Marketwired - May 12, 2015) - Wolverine Execution Services (WEX), a leading provider of premier technology and execution services, today announced the inclusion of options on futures...
Wolverine Execution Services Introduces New Vega Trading Applet, Providing New Efficiency When Trading Multiple Option Strikes
11 déc. 2014 12h48 HE | Wolverine Execution Services
CHICAGO, IL--(Marketwired - Dec 11, 2014) -  Wolverine Execution Services (WEX), a leading provider of premier technology and execution services, today announced the launch of WEX Vega Trader,...
Invest n Retire Adds Access to Wolverine Execution Services Into INR's Patented Record Keeping Software for Defined Contribution Plans and Separately Managed Accounts
30 juil. 2013 15h23 HE | Wolverine Execution Services; Invest n Retire
CHICAGO, IL and PORTLAND, OR--(Marketwired - Jul 30, 2013) - Wolverine Execution Services (WEX), a leading provider of value added trade execution services, and Invest n Retire, LLC (INR), an...
Families of SMA and Nationwide Children's Announce Multi-Million Dollar Award From NINDS to Advance CNS Gene Therapy for Spinal Muscular Atrophy
13 mars 2013 13h12 HE | Families of SMA
ELK GROVE VILLAGE, Ill., March 13, 2013 (GLOBE NEWSWIRE) -- Nationwide Children's Hospital (Columbus, OH) and Families of Spinal Muscular Atrophy (Elk Grove Village, IL) announce the award of a...
Pfizer Licenses Families of Spinal Muscular Atrophy Quinazoline Drug Program From Repligen
03 janv. 2013 09h31 HE | Families of SMA
ELK GROVE VILLAGE, Ill., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance...
Families of Spinal Muscular Atrophy Committed $2.5 Million to Funding SMA Research in 2012
31 déc. 2012 10h06 HE | Families of SMA
ELK GROVE VILLAGE, Ill., Dec. 31, 2012 (GLOBE NEWSWIRE) -- Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research...
Families of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapies
28 déc. 2012 10h07 HE | Families of SMA
ELK GROVE VILLAGE, Ill., Dec. 28, 2012 (GLOBE NEWSWIRE) -- Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research...
Repligen Initiates Phase 1b Trial of RG3039 for Spinal Muscular Atrophy Licensed From Families of SMA
26 sept. 2012 16h17 HE | Families of SMA
ELK GROVE VILLAGE, Ill., Sept. 26, 2012 (GLOBE NEWSWIRE) -- Repligen Corporation has initiated a Phase 1b clinical study of RG3039, a novel small molecule drug candidate for the potential treatment of...
2012 Innovation in Action Award Winners Announced at SMA Summit
24 sept. 2012 12h05 HE | SMA Strategy Meets Action
BOSTON, MA--(Marketwire - Sep 24, 2012) - Strategy Meets Action (SMA), a leading insurance strategic advisory firm, announced the winners of the SMA Innovation in Action Awards during its...